Tag Archives: CLBS

Top 10 Undervalued Stocks To Invest In 2021

Shares of Tivity Health Inc (NASDAQ:TVTY) have earned a consensus recommendation of “Buy” from the ten ratings firms that are currently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and seven have issued a buy rating on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $47.57.

Several research analysts have commented on TVTY shares. Piper Jaffray Companies restated a “buy” rating and set a $49.00 price objective on shares of Tivity Health in a research report on Tuesday, April 24th. Zacks Investment Research downgraded shares of Tivity Health from a “hold” rating to a “sell” rating in a research report on Wednesday, July 18th. BidaskClub downgraded shares of Tivity Health from a “hold” rating to a “sell” rating in a research report on Friday, July 27th. ValuEngine downgraded shares of Tivity Health from a “hold” rating to a “sell” rating in a research report on Saturday, June 2nd. Finally, Chardan Capital upgraded shares of Tivity Health from a “neutral” rating to a “buy” rating and set a $42.00 price objective for the company in a research report on Monday, June 4th.

Top 10 Undervalued Stocks To Invest In 2021: Anadarko Petroleum Corporation(APC)

Anadarko Petroleum Corporation is among the world’s largest independent exploration and production companies, with approximately 2.1 billion barrels of oil equivalent (BOE) of proved reserves at December 31, 2015. Anadarko’s mission is to deliver a competitive and sustainable rate of return to shareholders by developing, acquiring, and exploring for oil and natural-gas resources vital to the world’s health and welfare. Anadarko’s asset portfolio is aimed at delivering long-term value to stakeholders by combining a large inventory of development opportunities in the U.S. onshore with high-potential worldwide offshore exploration and development activities. Anadarko’s asset portfolio includes U.S. onshore resource plays in the Rocky Mountains, the southern United States, the Appalachian basin, and Alaska.   Advisors’ Opinion:

  • [By ]

    Last month, Chevron (NYSE: CVX) unveiled plans to acquire Anadarko Petroleum (NYSE: APC) for $33 billion in cash and stock. Anadarko execs signed on the dotted line, agreeing to a $1 billion breakup fee should the deal be scuttled for any reason. That was a mistake, particularly knowing there was another interested suitor.

  • [By Garrett Baldwin]

    See Now: Our founder just released his No. 1 pick for 2019. Don’t miss this. See the urgent briefing here…

    Walt Disney Co. (NYSE: DIS) unveiled its highly anticipated streaming service on Thursday. The service, Disney+, will launch Nov. 12 and cost $6.99 per month or $69 per year. The service will include television shows and films from its extended universe of programming – including the Star Wars and Marvel series. Disney said that all of its new films will be available on the service as soon as their theatrical windows have ended. In merger news, Chevron Corp. (NYSE: CVX) announced plans to purchase Anadarko Petroleum Corp.(NYSE: APC) as the oil major continues to push into the U.S. shale business. Shares of APC popped 32% in pre-market hours after Chevron announced the $33 billion bid. This is the largest energy merger since 2016 after Royal Dutch Shell Plc. (NYSE: RDS.A) purchased BG Group. The news sent shares of companies that operate in the Permian basin in West Texas even higher this morning. Look for other earnings reports from PNC Financial Services Group Inc.(NYSE: PNC) and Infosys Ltd.(NASDAQ: INFY).
    This Is How You Can Grow Incredibly Rich Buying Straight-Up Stocks

    Right now, even with all the market uncertainty, there’s truly a ridiculous amount of money to be made from stocks if you follow this secret.

Top 10 Undervalued Stocks To Invest In 2021: Fitbit, Inc.(FIT)

Fitbit, Inc. provides wearable health and fitness tracking devices. It offers various products, including Fitbit Zip, an entry-level wireless tracker that allows users to track daily activity statistics, such as steps, distance, calories burned, and active minutes; Fitbit One, a clippable wireless tracker, which tracks floors climbed and sleep, as well as daily steps, distance, calories burned, and active minutes; Fitbit Flex, a wristband-style tracker that tracks steps, distance, calories burned, active minutes, and sleep; and Fitbit Charge, an activity and sleep wristband, which tracks steps, distance, calories burned, active minutes, floors climbed, and sleep. The company also provides Fitbit Alta, a customizable wristband that offers call, text, and calendar notifications when paired with the users phone and SmartTrack automatic exercise recognition; and Fitbit Charge HR, a wireless heart rate and activity wristband. In addition, it offers Fitbit Blaze, a smart fitness watch that provides multi-sport functionality, tracks outdoor cycling activity, and provides run cues; Fitbit Surge, a fitness watch that features a GPS watch, heart rate tracker, activity tracker, and smartwatch; Aria, a Wi-Fi connected scale that tracks weight, body fat percentage, and body mass index; and Fitbit accessories that include bands and frames for Fitbit Blaze, bands for Fitbit Alta, colored bands for Fitbit Flex, colored clips for Fitbit One and Fitbit Zip, device charging cables, wireless sync dongles, band clasps, sleep bands, and Fitbit apparel. The company offers its products through consumer electronics and specialty retailers, e-Commerce retailers, sporting goods and outdoors retailers, and wireless carriers; and corporate wellness channels, as well as directly worldwide. The company was formerly known as Healthy Metrics Research, Inc. and changed its name to Fitbit, Inc. in October 2007. Fitbit, Inc. was founded in 2007 and is headquartered in San Francisco, California.

Advisors’ Opinion:

  • [By Evan Niu, CFA]

    Google has so far struggled in making a name for itself in wearables and smartwatches, as Wear OS (initially named Android Wear) failed to gain any meaningful traction and many prominent hardware partners ditched the platform. Apple and Fitbit (NYSE:FIT) currently lead the way in smartwatches, but Google hopes to take another swing with its forthcoming Pixel Watch. As part of those efforts, Google recently bought smartwatch tech and acqui-hired employees from Fossil for $40 million.

  • [By Daniel Sparks]

    Three stories in tech stood out this week.

    Fitbit (NYSE:FIT) showed off new devices with an emphasis on affordability. Facebook (NASDAQ:FB) CEO Mark Zuckerberg shared the company’s plans to beef up messaging and stories on its platforms. Eventbrite’s (NYSE:EB) stock took a big hit after its quarterly results came out.

    Here’s a closer look.

  • [By Stephan Byrd]

    Press coverage about Fitbit (NYSE:FIT) has trended somewhat positive recently, according to InfoTrie. The research group ranks the sentiment of press coverage by reviewing more than 6,000 blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Fitbit earned a coverage optimism score of 2.00 on their scale. InfoTrie also gave news coverage about the scientific and technical instruments company an news buzz score of 4 out of 10, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Evan Niu, CFA]

    After a couple challenging years, Fitbit (NYSE:FIT) has started to mount a turnaround. The company has already returned to profitability. In no uncertain terms, the Versa is driving that progress, positioned as a mainstream smartwatch that can appeal to average consumers. Versa’s predecessor, the Iconic, in contrast, was a flop because it was priced too high and targeted a smaller niche of performance users.

Top 10 Undervalued Stocks To Invest In 2021: Natus Medical Incorporated(BABY)

Natus Medical Incorporated provides neurodiagnostic and newborn care products worldwide. The company offers healthcare products used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Its product offerings include neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and incubators to control the newborn?s environment; and software systems for managing and tracking disorders and diseases. The company provides newborn hearing screening product lines consisting of the ALGO, ABaer, AuDX, and Echo-Screen newborn hearing screeners; and hearing screening supply products that are used with newborn hea ring screening devices. It also offers diagnostic hearing assessment product lines, which include the Navigator Pro system, the Scout sport portable diagnostic device, and the AuDX PRO; and diagnostic hearing supply products. In addition, the company provides monitoring systems, balance and mobility products, newborn brain injury diagnostic products, thermoregulation products, and jaundice management products. Further, it offers photometers, radiometers, patient warming lamps, neonatal heatshields, pediatric scales, blanket warming cabinets, exam lights, oxygen hoods, restraining boards, and newborn circumstraints; neonatal noise attenuators, phototherapy eye masks, and x-ray shields for reproductive organs; and newborn screening data management products. The company serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was founded in 1987 and is headquartered in San Carlos, California.

Advisors’ Opinion:

  • [By Logan Wallace]

    Shares of Natus Medical Inc (NASDAQ:BABY) have been assigned a consensus recommendation of “Hold” from the five analysts that are presently covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a sell rating, one has issued a hold rating and one has given a buy rating to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $36.00.

  • [By Stephan Byrd]

    COPYRIGHT VIOLATION NOTICE: “Natus Medical Inc (BABY) Holdings Lifted by Los Angeles Capital Management & Equity Research Inc.” was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this story can be read at www.tickerreport.com/banking-finance/4219997/natus-medical-inc-baby-holdings-lifted-by-los-angeles-capital-management-equity-research-inc.html.

Top 10 Undervalued Stocks To Invest In 2021: MobileIron, Inc.(MOBL)

MobileIron, Inc. provides a purpose-built mobile IT platform that enables enterprises to secure and manage mobile applications, content, and devices while providing their employees with device choice, privacy, and a native user experience. Its MobileIron platform offers mobile device management capabilities that enable IT to securely manage mobile devices across mobile operating systems and provide secure corporate email, automatic device configuration, and certificate-based security; and mobile application management functionality, which helps IT manage the entire apps lifecycle, from making apps available in the enterprise app storefront, securing applications on the device, enforcing user authentication, isolating them from personal apps, and retiring them as necessary. The companys platform also provides mobile content management that enables IT to provide secure mobile access to enterprise documents residing in SharePoint, file shares, and other enterprise and cloud content repositories, as well as secures email attachments. In addition, its platform offers advanced mobile security services, comprising VPN functions, which allows mobile apps to access enterprise resources through a secure application communication channel, eliminating the need for device VPN; Single Sign-On that provide access to multiple enterprise apps with a single authentication; and Help@Work, which mirrors the users screen onto the IT management console that enables IT support personnel to resolve the issue. The company serves financial service, government, healthcare, legal, manufacturing, professional service, retail, technology, and telecommunication industries in the United States and internationally. MobileIron, Inc. was founded in 2007 and is headquartered in Mountain View, California.

Advisors’ Opinion:

  • [By Shane Hupp]

    Mobileiron (NASDAQ:MOBL) and FalconStor Software (OTCMKTS:FALC) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability.

  • [By Motley Fool Transcribers]

    MobileIron Inc (NASDAQ:MOBL)Q42018 Earnings Conference CallFeb. 07, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Undervalued Stocks To Invest In 2021: Nexstar Broadcasting Group Inc.(NXST)

Nexstar Broadcasting Group, Inc., a television broadcasting and digital media company, focuses on the acquisition, development, and operation of television stations and interactive community Websites in medium-sized markets in the United States. It provides free over-the-air programming to television viewing audiences. The company, through various local service agreements, also offers sales, programming, and other services to stations and digital multi-cast channels owned and/or operated by independent third parties. As of December 31, 2011, it owned, operated, programmed, or provided sales and other services to 55 television stations and 11 digital multi-cast channels in 32 markets in the states of Illinois, Indiana, Maryland, Missouri, Montana, Texas, Pennsylvania, Louisiana, Arkansas, Alabama, New York, Florida, Wisconsin, and Michigan. The company?s stations reach approximately 10.6 million viewers. Nexstar Broadcasting Group, Inc. was founded in 1996 and is based in Irving, Texas.

Advisors’ Opinion:

  • [By Shane Hupp]

    Barrington Research reaffirmed their buy rating on shares of Nexstar Media Group (NASDAQ:NXST) in a report issued on Tuesday. They currently have a $110.00 target price on the stock. Barrington Research also issued estimates for Nexstar Media Group’s Q2 2019 earnings at $1.84 EPS, Q3 2019 earnings at $1.67 EPS, Q4 2019 earnings at $2.07 EPS, Q1 2020 earnings at $1.51 EPS, Q2 2020 earnings at $2.40 EPS, Q3 2020 earnings at $2.96 EPS, Q4 2020 earnings at $4.49 EPS and FY2021 earnings at $9.10 EPS.

  • [By Shane Hupp]

    Nexstar Media Group Inc (NASDAQ:NXST) – Research analysts at B. Riley decreased their Q3 2018 EPS estimates for Nexstar Media Group in a research note issued on Thursday, September 6th. B. Riley analyst B. Crockett now anticipates that the company will post earnings per share of $2.07 for the quarter, down from their previous estimate of $2.19. B. Riley currently has a “Buy” rating and a $92.00 price objective on the stock. B. Riley also issued estimates for Nexstar Media Group’s Q4 2018 earnings at $3.22 EPS, FY2018 earnings at $8.14 EPS, FY2019 earnings at $7.14 EPS and FY2020 earnings at $10.51 EPS.

  • [By Ethan Ryder]

    These are some of the headlines that may have impacted Accern Sentiment’s scoring:

    Get Nexstar Media Group alerts:

    Nexstar Media Group Inc (NXST) Given Consensus Rating of “Buy” by Analysts (americanbankingnews.com) Nexstar Media Group Inc (NXST) Insider Sells $11,956.50 in Stock (americanbankingnews.com) Nexstar Media Group (NXST) Cut to “Hold” at Noble Financial (americanbankingnews.com) Nexstar Media Group Inc to Post Q3 2018 Earnings of $1.94 Per Share, Barrington Research Forecasts (NXST) (americanbankingnews.com) Get Active Home Medical and Mobility (wdtn.com)

    Shares of NXST opened at $81.40 on Thursday. Nexstar Media Group has a 52-week low of $56.65 and a 52-week high of $89.75. The company has a debt-to-equity ratio of 2.59, a quick ratio of 2.43 and a current ratio of 2.43. The firm has a market capitalization of $3.57 billion, a PE ratio of 20.45, a price-to-earnings-growth ratio of 1.61 and a beta of 1.88.

Top 10 Undervalued Stocks To Invest In 2021: GlycoMimetics, Inc.(GLYC)

We are a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using our expertise in carbohydrate chemistry and knowledge of carbohydrate biology, we are developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles they play in inflammation, cancer and infection. We believe this represents an innovative approach to drug discovery to treat a wide range of diseases.
We are focusing our initial efforts on drug candidates for rare diseases that we believe will qualify for orphan drug designation.   Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    GlycoMimetics Inc (NASDAQ:GLYC)Q42018 Earnings Conference CallMarch 06, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    GlycoMimetics (NASDAQ:GLYC) was upgraded by investment analysts at BidaskClub from a “hold” rating to a “buy” rating in a research report issued on Wednesday.

  • [By Max Byerly]

    BidaskClub downgraded shares of GlycoMimetics (NASDAQ:GLYC) from a sell rating to a strong sell rating in a research report sent to investors on Saturday morning.

  • [By Joseph Griffin]

    GlycoMimetics (NASDAQ:GLYC)’s stock had its “buy” rating reiterated by equities research analysts at Stifel Nicolaus in a research report issued to clients and investors on Sunday. They presently have a $24.00 price target on the biotechnology company’s stock. Stifel Nicolaus’ target price would suggest a potential upside of 64.16% from the company’s previous close.

Top 10 Undervalued Stocks To Invest In 2021: Caladrius Biosciences, Inc.(CLBS)

Caladrius Biosciences, Inc. (“we,” “us,” “our,” “Caladrius” or the “Company”), through its subsidiary, PCT, LLC, a Caladrius CompanyTM (“PCT”), is a leading provider of development and manufacturing services to the cell therapy industry (which includes cell-based gene therapy). PCT has significant cell therapy-specific experience and expertise, an expansive list of noteworthy clients and significant revenue growth over the past two years. Notably, PCT and Hitachi Chemical Co. America, Ltd. and Hitachi Chemical Co., Ltd. ( collectively “Hitachi Chemical”) recently entered into a strategic collaboration to accelerate the creation of a global commercial cell therapy development and manufacturing enterprise with deep engineering expertise.   Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    News coverage about Caladrius Biosciences (NASDAQ:CLBS) has trended somewhat positive on Friday, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Caladrius Biosciences earned a coverage optimism score of 0.17 on Accern’s scale. Accern also gave news headlines about the biotechnology company an impact score of 45.4362129030389 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Undervalued Stocks To Invest In 2021: Home Federal Bancorp Inc.(HOME)

Home Federal Bancorp, Inc. operates as the holding company for Home Federal Bank that provides financial products and services to consumers and businesses. The company?s deposit products include checking accounts, money market deposit accounts, savings accounts, and certificates of deposits. Its loan products portfolio comprises one-to-four family residential real estate, real estate construction, and commercial and multifamily real estate loans; commercial business loans for various business purposes, such as working capital and equipment financing, and capital and general investment; and consumer loans, including home equity loans and lines of credit, savings account loans, automobile loans, recreational vehicle loans, and personal unsecured loans. The company offers its products and services in the Treasure Valley region of southwestern Idaho, including Ada, Canyon, Elmore, and Gem counties; the Tri-County region of Central Oregon comprising the counties of Crook, Desc hutes, and Jefferson, as well as the communities of Eugene, Grants Pass, and Medford; and Lane, Josephine, Jackson, and Multnomah counties in Western Oregon. As of January 27, 2012, it operated 28 full-service banking offices. The company was founded in 1920 and is headquartered in Nampa, Idaho.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    AT HOME GROUP INC (NYSE:HOME)Q42019 Earnings Conference CallMarch 27, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on At Home Group (HOME)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Shares of At Home Group Inc (NYSE:HOME) have been assigned an average rating of “Buy” from the twelve analysts that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have issued a buy rating on the company. The average 12-month target price among analysts that have covered the stock in the last year is $32.00.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on At Home Group (HOME)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Undervalued Stocks To Invest In 2021: 8×8 Inc(EGHT)

8×8, Inc. develops and markets telecommunications services for Internet protocol (IP), telephony, and video applications. The company offers 8×8 Virtual Office Business Telephone Service, an alternative to traditional private branch exchange systems that offers automated attendants to assist callers; extension-to-extension dialing services; direct inward dial; conference bridge, 3-way calling, music on hold, call park/pick-up, call transfer, hunt groups, and do not disturb services; voice mail, including email alerts and direct transfer to mailbox; call waiting/caller-ID; distinctive tone ringing; and optional receptionist console applications. Its products also include 8×8 Complete Contact Center, an integrated hosted call center solution that consists of skill-based routing, multi-media management, real time monitoring and reporting, voice recording and logging, historical reporting, interactive voice response, CRM integration, and contact and case management tools; 8×8 IP Telephones; 8×8 Virtual Meeting, a video Web conferencing service; and 8×8 Managed Hosting and Cloud-Based Computing Solutions. In addition, the company offers 8×8 Virtual Office Pro Unified Communications that allows subscribers to manage business communications functions online and delivers various tools, such as Microsoft Outlook contacts and corporate directory integration; virtual meeting; Virtual Office Mobile extension; fax; call recording; presence management; and a view of voicemails, recordings, FAX messages, calls, and chat history. The company markets its services under 8×8 brand to end users through direct sales force, Web site, and third party resellers primarily in the United States. As of June 30, 2011, it had approximately 25,000 business customers. 8×8, Inc. was founded in 1987 and is headquartered in Sunnyvale, California.

Advisors’ Opinion:

  • [By Max Byerly]

    Equities research analysts at William Blair started coverage on shares of 8X8 (NASDAQ:EGHT) in a research report issued to clients and investors on Wednesday, The Fly reports. The firm set a “buy” rating on the technology company’s stock.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on 8X8 (EGHT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Anders Bylund]

    RingCentral (NYSE:RNG) led the way with a 26.3% surge, followed by 8×8 (NYSE:EGHT) at 13.8% and Vonage Holdings (NYSE:VG) scoring a 10.7% gain. All of these one-month returns crushed the broader market, as the S&P 500 benchmark notched just a 3% gain last month.

Top 10 Undervalued Stocks To Invest In 2021: Danaos Corporation(DAC)

Danaos Corporation is an international owner of containerships, chartering its vessels to many of the world’s largest liner companies. We are a corporation domesticated in the Republic of The Marshall Islands on October 7, 2005, under the Marshall Islands Business Corporations Act, after having been incorporated as a Liberian company in 1998 in connection with the consolidation of our assets under Danaos Holdings Limited. In connection with our domestication in the Marshall Islands we changed our name from Danaos Holdings Limited to Danaos Corporation. Our manager, Danaos Shipping Company Limited, or Danaos Shipping, was founded by Dimitris Coustas in 1972 and since that time it has continuously provided seaborne transportation services under the management of the Coustas family. Dr. John Coustas, our chief executive officer, assumed responsibility for our management in 1987. Dr.   Advisors’ Opinion:

  • [By Shane Hupp]

    Several large investors have recently bought and sold shares of the business. Royal Bank of Scotland Group PLC purchased a new stake in shares of Danaos during the third quarter worth $42,286,000. Greenwich Wealth Management LLC purchased a new stake in shares of Danaos during the fourth quarter worth $393,000. Renaissance Technologies LLC lifted its position in shares of Danaos by 209.5% during the third quarter. Renaissance Technologies LLC now owns 284,320 shares of the shipping company’s stock worth $341,000 after acquiring an additional 192,456 shares in the last quarter. O Shaughnessy Asset Management LLC purchased a new stake in shares of Danaos during the third quarter worth $176,000. Finally, Acadian Asset Management LLC purchased a new stake in shares of Danaos during the third quarter worth $112,000. Hedge funds and other institutional investors own 17.85% of the company’s stock.

    ILLEGAL ACTIVITY NOTICE: “Danaos (DAC) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPS” was published by Ticker Report and is the property of of Ticker Report. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at www.tickerreport.com/banking-finance/4168528/danaos-dac-announces-quarterly-earnings-results-beats-estimates-by-0-05-eps.html.

    About Danaos

  • [By Motley Fool Transcribers]

    Danaos Corp (NYSE:DAC)Q42018 Earnings Conference CallFeb. 20, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Best Casino Stocks To Buy For 2019

Tigercoin (CURRENCY:TGC) traded down 2.7% against the US dollar during the 1 day period ending at 17:00 PM E.T. on July 5th. One Tigercoin coin can currently be bought for $0.0051 or 0.00000079 BTC on major cryptocurrency exchanges. Over the last week, Tigercoin has traded 19.7% higher against the US dollar. Tigercoin has a market cap of $223,778.00 and $28.00 worth of Tigercoin was traded on exchanges in the last day.

Here is how related cryptocurrencies have performed over the last day:

Get Tigercoin alerts:

Fusion (FSN) traded 1.3% lower against the dollar and now trades at $2.69 or 0.00041270 BTC. DAO.Casino (BET) traded 12.6% higher against the dollar and now trades at $0.0246 or 0.00000378 BTC. Joulecoin (XJO) traded down 3.7% against the dollar and now trades at $0.0090 or 0.00000138 BTC. C-Bit (XCT) traded 40.7% lower against the dollar and now trades at $0.0006 or 0.00000009 BTC. Save and Gain (SANDG) traded up 17.4% against the dollar and now trades at $0.0042 or 0.00000065 BTC. CaliphCoin (CALC) traded flat against the dollar and now trades at $0.0001 or 0.00000001 BTC. United Bitcoin (UBTC) traded 10.1% lower against the dollar and now trades at $4.36 or 0.00067046 BTC. BitSerial (BTE) traded down 1.3% against the dollar and now trades at $0.0036 or 0.00000055 BTC. Super Bitcoin (SBTC) traded 4.3% lower against the dollar and now trades at $5.21 or 0.00080098 BTC. BetaCoin (BET) traded down 2.7% against the dollar and now trades at $0.0018 or 0.00000028 BTC.

Tigercoin Profile

Best Casino Stocks To Buy For 2019: Cellect Biotechnology Ltd. (APOP)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading.
    Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading.
    Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading.
    MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading.
    Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan.
    Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading.
    MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading.
    Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results.
    Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading.
    Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings.
    Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.

     

  • [By Shane Hupp]

    Cellect Biotechnology (NASDAQ: APOP) is one of 105 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its competitors? We will compare Cellect Biotechnology to related companies based on the strength of its valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

  • [By Shane Hupp]

    CELLECT BIOTECH/S (NASDAQ:APOP)‘s stock had its “buy” rating reiterated by HC Wainwright in a research report issued on Tuesday. They presently have a $14.00 price target on the stock. HC Wainwright’s target price suggests a potential upside of 91.00% from the stock’s previous close.

  • [By Stephan Byrd]

    Media stories about CELLECT BIOTECH/S (NASDAQ:APOP) have been trending somewhat positive recently, according to Accern. The research firm ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CELLECT BIOTECH/S earned a daily sentiment score of 0.18 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.3583768207142 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Best Casino Stocks To Buy For 2019: region(XIV)

Advisors’ Opinion:

  • [By Money Morning News Team]

    This led some traders to purchase leveraged ETFs that move inverse to the VIX, like theVelocityShares Daily Inv VIX Short Term(Nasdaq: XIV).

    The VIX is a derivative of the broad S&P 500, and the XIV is a derivative of that derivative.

Best Casino Stocks To Buy For 2019: Caladrius Biosciences, Inc.(CLBS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Own For 2018

&l;p&g;&l;img class=&q;dam-image shutterstock size-large wp-image-1060141868&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1060141868/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Shutterstock

With just over a week to go until&a;nbsp;Tax Day (it&s;s&a;nbsp;&l;a href=&q;https://www.forbes.com/sites/kellyphillipserb/2018/01/04/irs-announces-2018-filing-season-opens-january-29-reminds-taxpayers-about-delayed-refunds/#587ab89410da&q;&g;April 17 this year&l;/a&g;), you have a few options available if you still haven&s;t yet filed your tax return. You can:

&l;/p&g;&l;ul&g;&l;li&g;Call and hope to get a last-minute tax appointment;&l;/li&g;

&l;li&g;Download tax prep software and figure you&s;ll squeeze the time to file while binge-watching &l;em&g;Stranger Things&l;/em&g;;&l;/li&g;

&l;li&g;Rock back and forth quietly under your desk while promising to be more prepared next year; or&l;/li&g;

&l;li&g;You can join the nearly 10 million taxpayers who are expected to file for an extension.&l;/li&g;

Top 10 Stocks To Own For 2018: Exelon Corporation(EXC)

Advisors’ Opinion:

  • [By Horizon Investments]

    For the past year, Exelon Corp. (EXC) has had a roller coaster ride, with the stock having plummeted 15% since September 2012 – the company had announced a dividend cut of 41%, which led to a drop in the share price. Separately, the recent weak PJM auction prices did not bode well for the company. However, I believe the worst is priced in the stock price, and the company’s management is committed to improving its financial flexibility and cost structure in order to strengthen its financial performance. Also, the company is planning to incur capital expenditure (CAPEX) in the upcoming years, which will result in rate base growth for Exelon.

  • [By Monica Gerson]

    Exelon Corporation (NYSE: EXC) is expected to report its quarterly earnings at $0.68 per share on revenue of $7.52 billion.

    CST Brands Inc (NYSE: CST) is projected to report its quarterly earnings at $0.22 per share on revenue of $2.30 billion.

  • [By Casey Wilson]

    That brings us to General Electric Co. (NYSE: GE). The 125-year-old American mainstay signed a deal with Exelon Corp. (NYSE: EXC) last fall for the energy utility to use its own predictive analytics software, fittingly dubbed “Predix.”

Top 10 Stocks To Own For 2018: PAR Technology Corporation(PAR)

Advisors’ Opinion:

  • [By Lisa Levin]

    PAR Technology Corporation (NYSE: PAR) shares were also up, gaining 15 percent to $6.59. Par Technology reported Q4 adjusted earnings of $0.13 per share on revenue of $56.8 million.

  • [By Lisa Levin]

    On Tuesday, technology shares gained by 1.61 percent. Meanwhile, top gainers in the sector included Himax Technologies, Inc. (ADR) (NASDAQ: HIMX), up 13 percent, and PAR Technology Corporation (NYSE: PAR), up 9 percent.

Top 10 Stocks To Own For 2018: iShares Nasdaq Biotechnology Index Fund(IBB)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of Gilead Sciences have dipped 0.1% to $68.97 at 1:05 p.m. today, while the iShares Nasdaq Biotechnology ETF (IBB) has risen 0.4% to $296.51.

  • [By Kumar Abhishek]

    Shares of Foster City, California-based, biotech major, Gilead Sciences, Inc(NASDAQ:GILD) have been on a consistent decline in the last one year or so. After being one of the best performers in the biotech space since 2012, Gilead stock has lost more than 12% in last one year, while theNasdaq Composite (INDX:COMPX) has gained by more than 24% in the same period, resulting in a massive underperformance. Gilead stock has underperformedeven the iShares NASDAQ Biotech Index ETF (NASDAQ:IBB) which has returned more than 14% during the same period. Gilead stock has been making lower lows and lower highs going into the earnings, indicating a clear downtrend in the stock. The stock hit its 52 week low of $69.78 recently on January 24th, just days ahead of its Q4 earnings result. Gilead Sciences, Incis scheduled to report its Q4 2016 and FY 2016 earnings on 7th of February, after the market close.

  • [By Ben Levisohn]

    Biotech stocks are having a great day today–iShares Nasdaq Biotechnology ETF (IBB) has climbed 2.5% to $276.92–leading some to suggest that 2017 could be better for investors than 2016 was. Not Baird’s Brian Skorney and Michael Ulz, who “don’t think 2017 will be worse than 2016″ but “aren’t quite sure it will be much better.” They explain why:

    Agence France-Presse/Getty Images

    Short story is, growth products are slowing and large net price increases are appearing increasingly unsustainable, even if the government doesn’t intervene. The innovation cycle appears to be in a waning period and, so far, large-caps with boatloads of cash seem to be hesitant to act. 2017 should have some excitement. We may finally see a successful registrational study in Alzheimer’s disease (Axovant Sciences’ (AXON) intepirdine or Merck’s (MRK) verubecestat), CAR T will finally get to plead its case, and we may find out once and for all if those ‘transformational’ PCSK9s are just that…

    A steadily building pharma cash war chest is a big offsetting tailwind. As Princess Leia would say, “Help me M&A, you’re my only hope.”

    Skorney’s namesVertex Pharmaceuticals (VRTX),Sarepta Therapeutics (SRPT), and Curis (CRIS) his top biotech picks for 2017, while Ulz chosesBioMarin Pharmaceutical (BMRN) andParatek Pharmaceuticals (PRTK).

Top 10 Stocks To Own For 2018: CytRx Corporation(CYTR)

Advisors’ Opinion:

  • [By Roberto Pedone]

    Another under-$10 biotechnology player that’s starting to trend within range of triggering a major breakout trade is CytRx (CYTR), which has an oncology pipeline that includes two programs in clinical development for cancer indications: aldoxorubicin and tamibarotene. This stock has been moving to the upside during the last three months, with shares up by 21%.

    If you take a look at the chart for CytRx, you’ll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last two months, with shares moving between $2.27 on the downside and $2.68 on the upside. That consolidation pattern has occurred right above this stock’s 50-day and 200-day moving averages. Shares of CYTR have now started to break out above some near-term overhead resistance at $2.49 a share. That move is quickly pushing CYTR within range of triggering an even bigger breakout trade above the upper-end of its recent sideways trading chart pattern.

    Market players should now look for long-biased trades in CYTR if it manages to break out above some near-term overhead resistance levels at $2.68 to $2.80 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 154,838 shares. If that breakout triggers soon, then CYTR will set up to re-test or possibly take out its next major overhead resistance levels at $3.20 to $4 a share.

    Traders can look to buy CYTR off any weakness to anticipate that breakout and simply use a stop that sits right below its 200-day at $2.33 a share or below more support at $2.27 a share. One can also buy CYTR off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 10 Stocks To Own For 2018: Castlight Health, inc.(CSLT)

Advisors’ Opinion:

  • [By Todd Campbell]

    Castlight Health (NYSE:CSLT)share price climbed 13.2% Wednesday after an SEC filing revealed that Maverick Capital had significantly boosted its stake in the company to 10.6%.

Top 10 Stocks To Own For 2018: Western Asset Mortgage Capital Corporation(WMC)

Advisors’ Opinion:

  • [By Max Byerly]

    ValuEngine lowered shares of Western Asset Mortgage Capit (NYSE:WMC) from a buy rating to a hold rating in a research report report published on Wednesday.

Top 10 Stocks To Own For 2018: SPDR Wells Fargo Preferred Stock ETF (PSK)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    DWFI holds five other SSgA fixed income ETFs, including the SPDR Wells Fargo Preferred Stock ETF (NYSE: PSK). PSK is DWFI's largest holding at a weight of 25.2 percent. DWFI's second-largest holding is an allocation of almost 25 percent to the SPDR Nuveen Barclays Municipal Bond ETF (NYSE: TFI).

Top 10 Stocks To Own For 2018: comScore Inc.(SCOR)

Advisors’ Opinion:

  • [By Paul Ausick]

    comScore Inc. (NASDAQ: SCOR) dropped more than 10% on Tuesday to record a new 52-week low of $20.81. The stock closed at $23.22 on Monday. Volume was about 9 times the daily average of around 470,000 shares. The company’s stock will be de-listed from Nasdaq effective February 8 unless the company receives a stay from the exchange.

Top 10 Stocks To Own For 2018: Caladrius Biosciences, Inc.(CLBS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Caladrius Biosciences Inc (NASDAQ: CLBS) shares shot up 14 percent to $5.83 after the company posted upbeat Q4 results.

    Shares of Norsat International Inc (USA) (NYSE: NSAT) got a boost, shooting up 22 percent to $9.85 after the company reported the receipt of new indication of interest by Privet Fund Management LLP at $10.25 per share.

  • [By Lisa Levin] Related Chardan Analyst Suggests An AveXis-Ionis Pair Trade Why The Biogen-Ionis News Is A Boon For AveXis AveXis' (AVXS) CEO Sean Nolan on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related CLBS Earnings Scheduled For March 17, 2017 15 Biggest Mid-Day Gainers For Thursday Caladrius Biosciences beats by $0.07, beats on revenue (Seeking Alpha) Gainers
    Caladrius Biosciences Inc (NASDAQ: CLBS) shares rose 20.2 percent to $6.13 in pre-market trading after the company reported a narrower-than-expected quarterly loss.
    Arbutus Biopharma Corp (NASDAQ: ABUS) rose 12.3 percent to $3.20 in pre-market trading after the company disclosed that it has licensed LNP delivery technology to Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) for use in single messenger RNA product candidate.
    AveXis Inc (NASDAQ: AVXS) rose 12.2 percent to $81.66 in pre-market trading after the company reported topline data from Phase 1 trial of AVXS-101.
    TOP SHIPS Inc (NASDAQ: TOPS) shares rose 10.5 percent to $2.43 in pre-market trading after surging 109.52 percent on Thursday.
    ChipMOS TECHNOLOGIES INC. (NASDAQ: IMOS) rose 9.8 percent to $17.45 in pre-market trading after declining 0.44 percent on Thursday.
    Sino-Global Shipping America, Ltd. (NASDAQ: SINO) rose 8.3 percent to $3.38 in pre-market trading after climbing 23.81 percent on Thursday.
    Diana Containerships Inc (NASDAQ: DCIX) rose 7.6 percent to $2.99 in pre-market trading after surging 12.55 percent on Thursday.
    Steel Dynamics, Inc. (NASDAQ: STLD) rose 5.2 percent to $37.25 in pre-market trading. Steel Dynamics expects Q1 earnings of $0.77 to $0.81 per diluted share. The company also declared a quarterly cash dividend of $0.1550 per common share.
    Adobe Systems Incorporated (NASDAQ: ADBE)
  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Caladrius Biosciences (CLBS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Caladrius Biosciences Inc. (NASDAQ: CLBS) watchedits shares soar on Thursday after the company announced a private placement offering. In terms of the specifics, the company entered into securities purchase agreements with several accredited investors for the sale of 4,449,153 shares of its common stock in private placements of $21 million.

Top 10 Stocks To Own For 2018: News Corporation(NWS)

Advisors’ Opinion:

  • [By Monica Gerson]

    News Corp (NASDAQ: NWS) reported a profit of $506 million, or $0.87 per share for the year ended June 30, versus a year-ago loss of $2.08 billion, or $3.58 per share. Its revenue rose 2.7% to $8.89 billion. However, analysts were expecting earnings of $0.57 per share on revenue of $8.96 billion. News Corp shares fell 1.28% to close at $16.91 on Friday.

  • [By Joseph Griffin]

    New Media Inv Group (NYSE: NEWM) and News (NASDAQ:NWS) are both consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

Top 10 Low Price Stocks To Own Right Now

In what would be a blow to American aerospace giant Boeing, Delta Air Lines is set to order around 100 jetliners from European rival Airbus, according to two people familiar with the deal.

Atlanta-based Delta will announce a deal later Wednesday for the Airbus A321neo, the sources said. The agreement with Airbus maker will be accompanied by a planned purchase of Pratt & Whitney engines, they added.

Spokespeople for Delta (DAL)and Airbus declined to comment. Boeing (BA) said it had no comment. Delta’s board of directors is expected to meet Wednesday to vote on the Airbus purchase, the sources said.

Delta had been talking to Boeing about buying around 100 of its 737 Max 10 airliners, a person familiar with the matter said.

The move comes a day after Canada announced plans to ditch a deal with Boeing for new F/A-18 Super Hornets in favor of used fighters from Australia.

Boeing and Delta are embroiled in an ongoing trade dispute over the airline’s purchase of the smaller Canadian Bombardier C Series. Boeing has accused Bombardier of selling the C Series to Delta at unfairly low prices, and the U.S. Commerce Department has recommended a preliminary 300% tariff on the import of the jets. Bombardier and the Canadian government deny any unfair trade practices.

Top 10 Low Price Stocks To Own Right Now: The Joint Corp.(JYNT)

Advisors’ Opinion:

  • [By Monica Gerson]

    Joint Corp (NASDAQ: JYNT) is estimated to post a quarterly loss at $0.28 per share on revenue of $4.13 million.

    Synacor Inc (NASDAQ: SYNC) is projected to post a quarterly loss at $0.03 per share on revenue of $30.00 million.

Top 10 Low Price Stocks To Own Right Now: Vanguard Value ETF (VTV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Dynamic Advisor Solutions LLC bought a new stake in Vanguard Value ETF (NYSEARCA:VTV) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 3,421 shares of the company’s stock, valued at approximately $353,000.

Top 10 Low Price Stocks To Own Right Now: Permian Basin Royalty Trust(PBT)

Advisors’ Opinion:

  • [By Monica Gerson]

    The list of below stocks is notable as the shares have traded on sequentially increasing volume spanning the trading days from September 16 to September 20:

Top 10 Low Price Stocks To Own Right Now: Taylor Morrison Home Corporation(TMHC)

Advisors’ Opinion:

  • [By ]

    In his second “Executive Decision” segment, Cramer sat down with Sheryl Palmer, chairman, president and CEO of Taylor Morrison Homes (TMHC) , for a read on the state of the housing market.

Top 10 Low Price Stocks To Own Right Now: Caladrius Biosciences, Inc.(CLBS)

Advisors’ Opinion:

  • [By Lisa Levin] Related Chardan Analyst Suggests An AveXis-Ionis Pair Trade Why The Biogen-Ionis News Is A Boon For AveXis AveXis' (AVXS) CEO Sean Nolan on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related CLBS Earnings Scheduled For March 17, 2017 15 Biggest Mid-Day Gainers For Thursday Caladrius Biosciences beats by $0.07, beats on revenue (Seeking Alpha) Gainers
    Caladrius Biosciences Inc (NASDAQ: CLBS) shares rose 20.2 percent to $6.13 in pre-market trading after the company reported a narrower-than-expected quarterly loss.
    Arbutus Biopharma Corp (NASDAQ: ABUS) rose 12.3 percent to $3.20 in pre-market trading after the company disclosed that it has licensed LNP delivery technology to Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) for use in single messenger RNA product candidate.
    AveXis Inc (NASDAQ: AVXS) rose 12.2 percent to $81.66 in pre-market trading after the company reported topline data from Phase 1 trial of AVXS-101.
    TOP SHIPS Inc (NASDAQ: TOPS) shares rose 10.5 percent to $2.43 in pre-market trading after surging 109.52 percent on Thursday.
    ChipMOS TECHNOLOGIES INC. (NASDAQ: IMOS) rose 9.8 percent to $17.45 in pre-market trading after declining 0.44 percent on Thursday.
    Sino-Global Shipping America, Ltd. (NASDAQ: SINO) rose 8.3 percent to $3.38 in pre-market trading after climbing 23.81 percent on Thursday.
    Diana Containerships Inc (NASDAQ: DCIX) rose 7.6 percent to $2.99 in pre-market trading after surging 12.55 percent on Thursday.
    Steel Dynamics, Inc. (NASDAQ: STLD) rose 5.2 percent to $37.25 in pre-market trading. Steel Dynamics expects Q1 earnings of $0.77 to $0.81 per diluted share. The company also declared a quarterly cash dividend of $0.1550 per common share.
    Adobe Systems Incorporated (NASDAQ: ADBE)
  • [By Lisa Levin]

    Caladrius Biosciences Inc (NASDAQ: CLBS) shares shot up 14 percent to $5.83 after the company posted upbeat Q4 results.

    Shares of Norsat International Inc (USA) (NYSE: NSAT) got a boost, shooting up 22 percent to $9.85 after the company reported the receipt of new indication of interest by Privet Fund Management LLP at $10.25 per share.

  • [By Chris Lange]

    Caladrius Biosciences Inc. (NASDAQ: CLBS) watchedits shares soar on Thursday after the company announced a private placement offering. In terms of the specifics, the company entered into securities purchase agreements with several accredited investors for the sale of 4,449,153 shares of its common stock in private placements of $21 million.

Top 10 Low Price Stocks To Own Right Now: Newfield Exploration Company(NFX)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Large Caps. Our E&P coverage is pricing in $61/bbl WTI and $3.30 gas, and with a lower crude forecast the group is looking less compelling. We argue names that continue to demonstrate resource improvement at the low-end of the cost curve, namely in the Permian and STACK remain attractive, such as Concho Resources (CXO), Devon Energy (DVN), Newfield Exploration (NFX) and Pioneer Natural Resources (PXD). Noble (NBL) remains a compelling value, though has yet to commit to an accelerated US onshore drilling program.

  • [By Ben Levisohn]

    Lear also sees strong “upside potential” forConcho Resources (CXO), Pioneer Natural Resources (PXD) and Newfield Exploration (NFX) as well performance improves in the Permian/STACK, and also writes positively on Devon Energy (DVN).

  • [By Lisa Levin]

    In trading on Wednesday, energy shares fell by 1.27 percent. Meanwhile, top losers in the sector included Newfield Exploration Co. (NYSE: NFX), down 9 percent, and Parker Drilling Company (NYSE: PKD), down 14 percent.

  • [By Ben Levisohn]

    The large cap E&Ps we cover raised ~ $6.5 billion of equity in 2015 and are likely to consider additional issuance in 2016. Pioneer Natural Resources (PXD) raised $1.3 billion on January 5th and Hess Corp. (HES) raised $1.5 billion of equity/equity-linked earlier this month. We think highly leveraged companies such as Devon Energy,Encana andRange Resources (RRC) and companies with a large deficit (before asset sales), such asAnadarko Petroleum and Devon Energy, are most likely to consider raising equity. Additionally, we believe companies such as WPX Energy (WPX), Southwestern Energy (SWN), Marathon Oil, Continental Resources (CLR),Noble Energy and Newfield Exploration (NFX) could issue equity while several levered companies may be unwilling or unable to access equity markets. We do not think Apache, Canadian Natural Resource, EOG Resources (EOG), Occidental Petroleum orPioneer Natural Resources are likely to issue equity this year.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Newfield Exploration Co. (NYSE: NFX) which traded down about 7% at $28.44. The stocks 52-week range is $24.41 to $50.00. Volume was 2.5 million versus the daily average of 2.7 million shares.

  • [By Dan Caplinger]

    Wednesday was an up-and-down day for the stock market, which lost substantial ground early in the day only to climb back toward the unchanged mark by the end of the session. A slight rise for the Dow Jones Industrials led to yet another record-high close, and although other major market benchmarks weren’t quite as lofty, they nevertheless finished with only modest losses on the day. Generally favorable news and sentiment helped the market bounce back during the day, but some stocks still finished lower. Newfield Exploration (NYSE:NFX), Global Blood Therapeutics (NASDAQ:GBT), and Nautilus (NYSE:NLS) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

Top 10 Low Price Stocks To Own Right Now: iAnthus Capital Holdings, Inc. (ITHUF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Over the past few weeks, Benzinga has been sharing interviews with the top venture capital and investment firms operating in the cannabis industry. Among those focused on ancillary businesses that do not touch the plant, we profiled Snoop Dogg’s Casa Verde and Arcview Group partner, CanopyBoulder. Among those willing to get involved in plant-touching ventures, we presented MJIC, which claims it intends to become the “Amazon.com, Inc. (NASDAQ: AMZN) of weed,” and iAnthus Capital Holdings Inc (CNSX: IAN) (OTC: ITHUF), which raises capital for U.S.-based marijuana companies in Canadian capital markets.

  • [By Javier Hasse]

    Earlier this month, cannabis-focused financing and advisory firm iAnthus Capital Holdings Inc (CNSX: IAN) (OTC: ITHUF) announced it acquired Westchester-based Valley Agriceuticals, LLC, gaining access to New York’s nascent cannabis market.

  • [By Javier Hasse]

    The Green Solution received a $7.5 million loan facility from iAnthus Capital Holdings Inc (OTC: ITHUF).

    “This was also to accelerate expansion within Colorado and going into other states nation-wide.”

    Valens Groworks Corp (CNSX: VGW), a Canadian post-inspection applicant for cannabis cultivation and processing, raised C$500,000 ($381,431) under a convertible note to meet acquisition and expansion obligations.

  • [By ]

    Much of the focus of cannabis investors has been centered on Canada and California. This makes sense given that they are the two largest recreational (or soon to be) cannabis markets in the world. However, one publicly traded company with US-centric cannabis operations has taken a different approach. iAnthus Capital is listed in Canada on the CSE (OTCQB:ITHUF), but is headquartered in New York and incorporated in Delaware. Unlike other Canadian-listed cannabis companies, most of which are aiming to get in on the highly competitive green-rush in California and Canada, iAnthus has set its sights on becoming the dominant player on the U.S. East Coast.

Top 10 Low Price Stocks To Own Right Now: Cherry Hill Mortgage Investment Corporation(CHMI)

Advisors’ Opinion:

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston

Top 10 Low Price Stocks To Own Right Now: Pretium Resources, Inc.(PVG)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wednesday was a down day for the stock market, with the Dow Jones Industrial Average posting triple-digit losses even as broader benchmarks had much smaller moves. Market participants largely focused their attention on the inflation front, as March consumer price index numbers showed a 0.2% rise in the core rate excluding food and energy. Year-over-year price changes have accelerated, seemingly giving the Federal Reserve more justification to continue raising interest rates. Yet even though many stocks generally react unfavorably to inflation fears, there were some big gainers that had good news. Hilton Worldwide Holdings (NYSE:HLT), Pretium (NYSE:PVG), and Applied Optoelectronics (NASDAQ:AAOI) were among the best performers on the day. Here’s why they did so well.

  • [By WWW.MONEYSHOW.COM]

    Pretium Resources (PVG) remains on target with its development of what will be a world-class gold mine in British Columbia. The Brucejack property is slated to begin commercial production in mid-2017.

Top 10 Low Price Stocks To Own Right Now: The Herzfeld Caribbean Basin Fund, Inc.(CUBA)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    This "Trump pick" is a snub to the President’s trade and diplomatic reversals of Obama’s wins regarding Cuba. We are buying back Herzfeld Caribbean Basin Fund (CUBA), following in the footsteps of its founder, Tom Herzfeld, and his son Erik.

best penny stocks

Kinder Morgan (NYSE:KMI) may be a stock you are frustrated at because of the dividend cut late last year or because of the way management handled the situation. Regardless of your feelings, KMI is still an investment vehicle that can add value to your portfolio. The following analysis is going to focus on correlations of KMI to different commodities and it is my hope that investors recognize that certain catalysts in KMI’s growth profile will have materially different impacts.

Source: Wikimedia

Kinder Morgan’s Large Catalyst

I’ve talked previously about the company’s ability outperform via a few large catalysts. These are the Trans Mountain Pipeline Expansion project, a credit rating increase, a later dividend increase when stability is achieved and naturally, La Nina. Yet, I really want to focus on La Nina for this article, in light of new data regarding KMI’s correlations with commodities.

best penny stocks: EchoStar Corporation(SATS)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Incidentally, Facebook has secured shareholder approval for issuing Class C share at its shareholder meeting in June 2016, although it is yet to issue the shares.

    Other Companies With Dual-class Voting Shares
    Berkshire Hathaway Inc. (NYSE: BRK-A) and (NYSE: BRK-A), with Class A shares having 1/10th interest in the company but only 1/200th of voting power. Echostar Corporation (NASDAQ: SATS)’s CEO Charlie Ergen owns a 43.4 percent stake in the company through his holding of Class B shares but has 63.6 percent of the voting rights. Ford Motor Company (NYSE: F) uses the dual-class structure to give its founding family more voting power.

    Related Links:

best penny stocks: Caladrius Biosciences, Inc.(CLBS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Caladrius Biosciences Inc (NASDAQ: CLBS) shares shot up 14 percent to $5.83 after the company posted upbeat Q4 results.

    Shares of Norsat International Inc (USA) (NYSE: NSAT) got a boost, shooting up 22 percent to $9.85 after the company reported the receipt of new indication of interest by Privet Fund Management LLP at $10.25 per share.

  • [By Chris Lange]

    Caladrius Biosciences Inc. (NASDAQ: CLBS) watchedits shares soar on Thursday after the company announced a private placement offering. In terms of the specifics, the company entered into securities purchase agreements with several accredited investors for the sale of 4,449,153 shares of its common stock in private placements of $21 million.

  • [By Lisa Levin] Related Chardan Analyst Suggests An AveXis-Ionis Pair Trade Why The Biogen-Ionis News Is A Boon For AveXis AveXis' (AVXS) CEO Sean Nolan on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related CLBS Earnings Scheduled For March 17, 2017 15 Biggest Mid-Day Gainers For Thursday Caladrius Biosciences beats by $0.07, beats on revenue (Seeking Alpha) Gainers
    Caladrius Biosciences Inc (NASDAQ: CLBS) shares rose 20.2 percent to $6.13 in pre-market trading after the company reported a narrower-than-expected quarterly loss.
    Arbutus Biopharma Corp (NASDAQ: ABUS) rose 12.3 percent to $3.20 in pre-market trading after the company disclosed that it has licensed LNP delivery technology to Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) for use in single messenger RNA product candidate.
    AveXis Inc (NASDAQ: AVXS) rose 12.2 percent to $81.66 in pre-market trading after the company reported topline data from Phase 1 trial of AVXS-101.
    TOP SHIPS Inc (NASDAQ: TOPS) shares rose 10.5 percent to $2.43 in pre-market trading after surging 109.52 percent on Thursday.
    ChipMOS TECHNOLOGIES INC. (NASDAQ: IMOS) rose 9.8 percent to $17.45 in pre-market trading after declining 0.44 percent on Thursday.
    Sino-Global Shipping America, Ltd. (NASDAQ: SINO) rose 8.3 percent to $3.38 in pre-market trading after climbing 23.81 percent on Thursday.
    Diana Containerships Inc (NASDAQ: DCIX) rose 7.6 percent to $2.99 in pre-market trading after surging 12.55 percent on Thursday.
    Steel Dynamics, Inc. (NASDAQ: STLD) rose 5.2 percent to $37.25 in pre-market trading. Steel Dynamics expects Q1 earnings of $0.77 to $0.81 per diluted share. The company also declared a quarterly cash dividend of $0.1550 per common share.
    Adobe Systems Incorporated (NASDAQ: ADBE)

best penny stocks: MGE Energy Inc.(MGEE)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, utilities shares fell by 0.75 percent. Meanwhile, top losers in the sector included California Water Service Group (NYSE: CWT), down 7 percent, and MGE Energy, Inc. (NASDAQ: MGEE), down 6 percent.

best penny stocks: Mastercard Incorporated(MA)

Advisors’ Opinion:

  • [By David Zeiler]

    Ethereum has plenty of real-world catalysts driving it already:

    It’s become the foundation of the booming ICO phenomenon, through which cryptocurrency-based startups have raised millions of dollars in a matter of minutes. Most new tokens are either based on Ethereum and/or require users to buy the cryptocurrency with Ethereum. It’s Turing complete, which means the Ethereum network can function as a giant, global computer. That’s what makes Ethereum an ideal platform for applications like smart contracts. And it’s enabled the creation of a new kind of app, “Dapps,” or distributed applications that run on the network. Businesses are adopting it. The 150-plus companies in the Enterprise Ethereum Alliance include some of the world’s biggest and most prestigious corporations, such as JPMorgan Chase & Co. (NYSE:JPM), Microsoft Corp. (Nasdaq: MSFT), Mastercard Inc. (NYSE: MA), and Deloitte.

    Related: What’s the Best Cryptocurrency to Invest in Today?

  • [By Matthew Cochrane]

    With this mindset, it is no wonder that PayPal finished 2016 on a wave of deal-making momentum. In the past 12 months, PayPal completed agreements with a number of financial and tech companies including Alibaba Group Holding Ltd (NYSE: BABA), Citigroup Inc (NYSE: C), Facebook Inc (NASDAQ: FB), Mastercard Inc (NYSE: MA), Visa Inc (NYSE: V), and Vodafone Group Plc (NASDAQ: VOD).

  • [By Matthew Cochrane]

    Mastercard Inc’s (NYSE:MA) shares are now near all-time highs, as its consistent and steady growth has driven the stock to amazing heights since its IPO a little more than a decade ago. Since going public, Mastercard’s stock price has skyrocketed more than 2,400%! More recent investors have nothing to complain about either as shares have increased nearly 13% year-to-date. Its recent quarter is just another impressive benchmark in its life as a public company.

  • [By Dan Caplinger]

    Visa Inc. (NYSE:V) and MasterCard (NYSE:MA) aren’t the only two players in the credit card and electronic payments space, but they are the biggest and best-known. Both Visa and MasterCard have extended their reach across the globe, and both have high expectations in their trajectories for future growth. Yet after a big push in the stock market that has sent both of these financial stocks to all-time highs, investors need to know which of the two leaders in the card industry is more deserving of their attention. Let’s take a closer look at Visa and MasterCard, comparing them using several different metrics to see which company’s shares are the better buy.

best penny stocks: Hawaiian Holdings, Inc.(HA)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    Not surprisingly, shares of Hawaii-focused airline company Hawaiian Holdings (NASDAQ:HA) fell last Wednesday, following Kelly’s comments about Southwest Airlines expanding to Hawaii. However, while Southwest’s entry into the Hawaii market could cause some short-term disruption, it isn’t likely to hurt Hawaiian Airlines’ positioning in the long run.

  • [By Adam Levine-Weinberg]

    Investors had high expectations for Southwest Airlines (NYSE:LUV) and Hawaiian Holdings (NASDAQ:HA) leading up to their earnings reports last week. Between late June 2016 and mid-January, shares of Hawaiian Holdings climbed 50%. Southwest Airlines stock was close behind, with a gain of more than 35% over that period.

  • [By Adam Levine-Weinberg]

    While most of its fellow airline stocks were grounded last year, Hawaiian Holdings (NASDAQ:HA) soared to new heights. Shares of Hawaiian Airlines’ parent company rose 61% during 2016, according to data from S&P Global Market Intelligence.

best penny stocks: Cipher Pharmaceuticals Inc.(CPHR)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Cipher Pharmaceuticals (NASDAQ: CPHR) is said to have hired an investment bank to explore strategic alternatives, according to sources as reported by Reuters on Monday. The sources said a potential sale of the Canada-based company is being considered. Cipher declined comment on the report.